Literature DB >> 30166312

Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing.

Maria Alexiadis1, Simone M Rowley2, Simon Chu1, Dilys T H Leung1, Colin J R Stewart3,4, Kaushalya C Amarasinghe2, Ian G Campbell2, Peter J Fuller5.   

Abstract

Adult granulosa cell tumor (aGCT), the most common malignant ovarian sex cord-stromal tumor, is characterized by the forkhead transcription factor FOXL2 p.C134W somatic mutation. Late recurrences are relatively common but the molecular mechanisms of relapse or aggressive behavior are not known. The mutational landscape of FOXL2 p.C134W mutation-positive tumors (n = 22) was determined using whole-exome sequencing (WES). An average of 64 coding and essential splice-site variants were identified per tumor. As the TERT promoter region is poorly covered by the WES, targeted sequencing identified the TERT -124C>T promoter mutation as the only recurrent mutation (∼40% of cases). Pathway analysis suggested an association with DNA replication/repair and the EGFR family canonical pathways. Copy number analysis confirmed that gains of chromosomes 12 and 14 occur in approximately 30% of aGCT and loss of chromosome 22 occurs in approximately 40% of cases. In summary, exome-wide analysis of the mutational landscape of aGCT revealed that, except for the TERT promoter mutation, recurrence and/or aggressive behavior is not defined by activation or loss of specific genes. IMPLICATIONS: This study found that although aGCTs are defined by the presence of a common FOXL2 gene mutation, recurrence and/or aggressive behavior cannot be attributed to subsequent mutation of specific gene(s) or pathways; however, there is a high frequency of the TERT -124C>T promoter mutation, which is associated with more aggressive disease. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30166312     DOI: 10.1158/1541-7786.MCR-18-0359

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  15 in total

Review 1.  Adult-type granulosa cell tumor of the ovary.

Authors:  Xiuwen Li; Bo Tian; Mengyan Liu; Chunlei Miao; Di Wang
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

2.  Adult Granulosa Cell Tumor With Sarcomatous Transformation: A Case Study With Emphasis on Molecular Alterations.

Authors:  Wissam Dahoud; Jesse Handler; Vamsi Parimi; Christian F Meyer; Stephanie L Wethington; James R Eshleman; Russell Vang; Brigitte M Ronnett; Deyin Xing
Journal:  Int J Gynecol Pathol       Date:  2021-12-03       Impact factor: 3.326

3.  Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.

Authors:  Victoria Cluzet; Marie M Devillers; Florence Petit; Stéphanie Chauvin; Charlotte M François; Frank Giton; Catherine Genestie; Nathalie di Clemente; Joëlle Cohen-Tannoudji; Céline J Guigon
Journal:  Oncogene       Date:  2019-11-19       Impact factor: 9.867

4.  Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup.

Authors:  Joline Roze; Glen Monroe; Joachim Kutzera; Jolijn Groeneweg; Ellen Stelloo; Sterre Paijens; Hans Nijman; Hannah van Meurs; Luc van Lonkhuijzen; Jurgen Piek; Christianne Lok; Geertruida Jonges; Petronella Witteveen; René Verheijen; Gijs van Haaften; Ronald Zweemer
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

5.  Familial Occurrence of Adult Granulosa Cell Tumors: Analysis of Whole-Genome Germline Variants.

Authors:  Joline F Roze; Joachim Kutzera; Wouter Koole; Margreet G E M Ausems; Kristi Engelstad; Jurgen M J Piek; Cor D de Kroon; René H M Verheijen; Gijs van Haaften; Ronald P Zweemer; Glen R Monroe
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

Review 6.  Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.

Authors:  Seiichi Mori; Osamu Gotoh; Kazuma Kiyotani; Siew Kee Low
Journal:  J Hum Genet       Date:  2021-06-07       Impact factor: 3.172

7.  Prevalence of predictive biomarkers in a large cohort of molecularly defined adult-type ovarian granulosa cell tumors.

Authors:  R Tyler Hillman; Douglas I Lin; Barrett Lawson; David M Gershenson
Journal:  Gynecol Oncol       Date:  2021-07-06       Impact factor: 5.304

Review 8.  Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review.

Authors:  Asaf Maoz; Koji Matsuo; Marcia A Ciccone; Shinya Matsuzaki; Maximilian Klar; Lynda D Roman; Anil K Sood; David M Gershenson
Journal:  Cancers (Basel)       Date:  2020-05-29       Impact factor: 6.639

9.  Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.

Authors:  Arnaud Da Cruz Paula; Edaise M da Silva; Sheila E Segura; Fresia Pareja; Rui Bi; Pier Selenica; Sarah H Kim; Lorenzo Ferrando; Mahsa Vahdatinia; Robert A Soslow; August Vidal; Sonia Gatius; Christopher G Przybycin; Nadeem R Abu-Rustum; Xavier Matias-Guiu; Brian P Rubin; Jorge S Reis-Filho; Deborah F DeLair; Britta Weigelt
Journal:  Mod Pathol       Date:  2020-03-12       Impact factor: 7.842

10.  FOXL2 homozygous genotype and chromosome instability are associated with recurrence in adult granulosa cell tumors of the ovary.

Authors:  Francois Kraus; Julie Dremaux; Wajd Altakfi; Magalie Goux; Léa Pontois; Henri Sevestre; Stéphanie Trudel
Journal:  Oncotarget       Date:  2020-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.